Oragenics (OGEN) Preferred Shares (2017 - 2024)
Oragenics' (OGEN) quarterly Preferred Shares came in at $1.6 million in Q3 2024, little changed YoY from $1.6 million in Q4 2023, and little changed on a QoQ basis from $1.6 million in Q2 2024.
Oragenics (OGEN) Preferred Shares (2017 - 2024) Analysis & Trends
Oragenics (OGEN) has 8 years of Preferred Shares data on file, last reported at $1.6 million in Q3 2024.
- Quarterly Preferred Shares changed 0.0% year-over-year to $1.6 million in Q3 2024, while the trailing twelve-month figure through Sep 2024 was $1.6 million (changed 0.0% YoY) and the FY2023 annual result came in at $1.6 million, changed 0.0% from the prior year.
- Preferred Shares was little changed at $1.6 million in Q3 2024, from $1.6 million in the prior quarter.
- In the past five years, Preferred Shares ranged from a high of $7.2 million in Q1 2020 to a low of $1.6 million in Q3 2022.
- A 5-year average of $3.1 million and a median of $2.7 million in 2021 frame the typical range for Preferred Shares.
- Annual changes were most pronounced in 2020 — Preferred Shares advanced 10.16% — and 2021, when it sank 62.97%.
- Tracing OGEN's Preferred Shares over 5 years: stood at $7.2 million in 2020, then slumped by 62.97% to $2.7 million in 2021, then plunged by 40.05% to $1.6 million in 2022, then changed by 0.0% to $1.6 million in 2023, then changed by 0.0% to $1.6 million in 2024.
- The last three Preferred Shares figures came in at $1.6 million (Q3 2024), $1.6 million (Q2 2024), and $1.6 million (Q1 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | - |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | - |
| 10 | Oragenics | 2.38 Mn | 2.38 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 1.59 Mn |
| Jun 30, 2024 | 1.59 Mn |
| Mar 31, 2024 | 1.59 Mn |
| Dec 31, 2023 | 1.59 Mn |
| Sep 30, 2023 | 1.59 Mn |
| Jun 30, 2023 | 1.59 Mn |
| Mar 31, 2023 | 1.59 Mn |
| Dec 31, 2022 | 1.59 Mn |
| Sep 30, 2022 | 1.59 Mn |
| Jun 30, 2022 | 2.66 Mn |
| Mar 31, 2022 | 2.66 Mn |
| Dec 31, 2021 | 2.66 Mn |
| Sep 30, 2021 | 2.66 Mn |
| Jun 30, 2021 | 2.66 Mn |
| Mar 31, 2021 | 2.66 Mn |
| Dec 31, 2020 | 7.17 Mn |
| Sep 30, 2020 | 7.17 Mn |
| Jun 30, 2020 | 7.17 Mn |
| Mar 31, 2020 | 7.17 Mn |
| Dec 31, 2019 | 6.51 Mn |